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Background-—The relationships between physical activity (PA) and both cardiovascular disease (CVD) and type 2 diabetes mellitus
(T2DM) have predominantly been estimated using categorical measures of PA, masking the shape of the dose-response
relationship. In this systematic review and meta-analysis, for the very ﬁrst time we are able to derive a single continuous PA metric
to compare the association between PA and CVD/T2DM, both before and after adjustment for a measure of body weight.
Methods and Results-—The search was applied to MEDLINE and EMBASE electronic databases for all studies published from
January 1981 to March 2014. A total of 36 studies (3 439 874 participants and 179 393 events, during an average follow-up
period of 12.3 years) were included in the analysis (33 pertaining to CVD and 3 to T2DM). An increase from being inactive to
achieving recommended PA levels (150 minutes of moderate-intensity aerobic activity per week) was associated with lower risk of
CVD mortality by 23%, CVD incidence by 17%, and T2DM incidence by 26% (relative risk [RR], 0.77 [0.71–0.84]), (RR, 0.83 [0.77–
0.89]), and (RR, 0.74 [0.72–0.77]), respectively, after adjustment for body weight.
Conclusions-—By using a single continuous metric for PA levels, we were able to make a comparison of the effect of PA on CVD
incidence and mortality including myocardial infarct (MI), stroke, and heart failure, as well as T2DM. Effect sizes were generally
similar for CVD and T2DM, and suggested that the greatest gain in health is associated with moving from inactivity to small
amounts of PA. ( J Am Heart Assoc. 2016;5:e002495 doi: 10.1161/JAHA.115.002495)
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I nsufﬁcient physical activity (PA) is a key risk factor fornoncommunicable diseases such as cardiovascular dis-
eases (CVD), cancer and diabetes mellitus.1 CVD is the
number 1 cause of death globally, with 17.5 million deaths
from CVD and 1.5 million deaths from diabetes in 2012,
representing 31% and 2.7% of global deaths, respectively.2,3
It has been over half a century since the pioneering studies
of bus drivers and then longshoremen, which ﬁrst established
the beneﬁcial impact of PA upon CVD risk.2,3 More recently, in
2010 the UK Chief Medical Ofﬁcer Sir Liam Donaldson
declared that the beneﬁts of regular PA on health, longevity,
and well-being “easily surpass the effectiveness of any drugs
or other medical treatment.”4
Current international recommendations for PA are to
achieve at least 150 minutes per week of moderate-intensity
aerobic PA, or 75 minutes per week of vigorous PA,5,6 and a
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higher level of 300 minutes per week of moderate-intensity
PA has been recommended to reduce the risk of cancer.7
These recommendations were typically constructed on sys-
tematic reviews and meta-analysis of epidemiological studies;
however, these reviews were not without limitations. Many
only assessed the beneﬁts of a single domain or facet of PA,
such as Lee and Paffenbarger,8 which examines only walking
and recreational activity. Most had pooled results based on
different ranges of categorical exposure measures (eg, “high”
or “low”), for example, Fujita et al.,9 which compares the sole
domain of walking on mortality, or Woodcock et al.,10 which
focuses on “nonvigorous” physical activity. Furthermore,
existing reviews, such as Jeon et al.,11 do not explore the
risk reductions after adjusting for body weight and therefore
do not allow for an assessment of the independent effect of
PA on health outcomes, and at least part of the observed
effect is likely to be mediated by maintenance of healthy
weight status.
The aim of this study was to conduct a systematic review
and meta-analysis to draw together the epidemiological
studies that assesses the independent association between
PA levels and both CVD and type 2 diabetes mellitus (T2DM)
outcomes, using a single continuous metric and adjusting for
body weight. In order to make comparable results across
disease domains, exposure data for physical activity was
converted to a common continuous metric of metabolic
equivalent of task (MET) hours per week. Although subject to
limitations from original studies, this metric allowed us to
study results in order to reﬂect international PA guidelines.
More important, it also allowed us to estimate the relative risk
(RR) associated with a unit increase in PA at any activity level,
and to explore the dose-response relationship between PA
and CVD or T2DM outcomes.
Methods
Eligibility Criteria
Studies considered for inclusion were prospective cohort
studies that measured PA levels where at least 2 of the
following domains were measured: leisure, household, active
travel, and occupational activity.
Estimates of the RR for incidence of or mortality from
CVDs or T2DM in participants free of disease at baseline had
to be reported. Studies that provided estimates for total CVD
were included under the main CVD incidence/mortality
results. Otherwise, any studies that reported individual CVD
outcomes, such as heart failure or myocardial infarct (MI),
were included in separate meta-analyses.
In addition, the RR had to be adjusted for a measure of body
weight (eg, continuous measurements of body weight, body
mass index, waist circumference, etc., or binary measures of
overweight, obesity, etc.). For consistency, all such measures
are referred to as “body weight.” If multiple studies measuring
the same outcome were published from the same cohort,
preference was given to that with the most years of follow-up in
the analysis. Studies were excluded if the PA measure was one
of ﬁtness, as opposed to a measure of time or volume of PA.
Only studies published in English were included.
Search Strategy
Relevant studies were identiﬁed by searching electronic
databases and supplemented by scanning the reference lists
of included studies and relevant systematic reviews. The
search was applied to MEDLINE and EMBASE electronic
databases for all studies published from January 1981 toMarch
2014. Key terms, among others, included “physical activity,”
“cardiovascular diseases,” “stroke,” “heart diseases,” and
“mortality.” The complete search strategy is attached as
supplemental online material.
Study Selection and Data Extraction
Identiﬁed titles and abstracts were initially obtained through
application of the search strategy, and these were divided
equally among 3 authors to be screened for inclusion on the
basis of title, with a fourth reviewer cross-checking a 10%
sample of exclusion decisions. The abstracts of studies
included after the initial screening were then independently
assessed by 2 reviewers for inclusion in the review, with
discrepancies referred to a third reviewer and resolved
through discussion. A single reviewer reviewed full-text
articles, with a second reviewer cross-checking undecided
cases and a random 10% sample of excluded articles. A single
reviewer performed data extraction, with a 10% sample check
conducted by a second reviewer. If any discrepancies arose
between reviewers, these were referred to a third reviewer for
discussion.
Assessment of Study Quality
A quality criteria scale at the study level was developed using
applicable elements from the Newcastle-Ottawa scale for
cohort studies.12 The developed scale was piloted on 10
studies and reﬁned accordingly, and is displayed in Table S1,
along with the assessments of quality for each included study.
This scale was previously used in the meta-analysis of walking
and cycling by Kelly et al.13
Conversion to Standard PA Units
RRs with SEs were obtained from each study for the various
reported levels of PA in relation to the reported health
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outcomes. The PA exposure in each study was converted to
MET hours per day above that expended by the baseline group
(referred to throughout as the inactive group) in order to
quantify the association on a comparable scale.
One MET is deﬁned as 1 kcal/kg and is approximately
equivalent to the energy cost of sitting quietly.14 This unit
was chosen because it provided a continuous variable that
could be converted to a single RR estimate for a selected
change in volume of PA. Conversion to this scale was
performed with reference to the Physical Activity Com-
pendium,14 which was developed for use in epidemiological
studies to standardize the assignment of MET intensities in
PA questionnaires.
If PA exposure estimates were not directly reported in the
form of MET hours, the Physical Activity Compendium was
used to convert the information provided about the amount of
PA conducted to our standard unit to reﬂect the time and
intensity of activity. Any reference to “moderate” PA was
assigned a value of 4.5 METs and vigorous activity a value of
6.5 METs, based on World Health Organization recommenda-
tions.5 Using the compendium, it was decided to assign any
references to “inactive behavior” a value of 1.5 METs, and
“light activity” a value of 2.5 METs, and average body weights
of 84 and 71 kg15 were assigned to men and women,
respectively, where no other information was provided by the
studies.
The rules for converting physical activity measures to a
standard metric of “Additional MET h/day” are listed in
Table S2.
Statistical Analysis
The relationship between RR and PA was assessed using
regression analysis for each study individually. In all cases, it
was assumed that the relationship between relative risk and
MET hours per week followed a 0.25 power transformation (ie,
RR=1+b9MET0.25, where b is a regression coefﬁcient).
Additional analyses, namely, both linear and log linear
associations, and power transformations of 0.375, 0.50, and
0.75 were also conducted to assess the sensitivity of the
ﬁndings to the method of parameterising the dose-response
relationship. The 0.25 power transformation was chosen for
the primary outcome measures because it closely models the
observed ﬁndings from previous studies that the RR for
chronic disease falls quickly with a small addition of PA, but
further increases of PA produce rapidly diminishing returns.
This transformation has previously been used in a meta-
analysis of the effect of PA on all-cause mortality10 using the
Alaike’s Information Criterion, in order to select the transfor-
mation that best ﬁts the data.16
Additionally, a categorical analysis was conducted, where
the dose-response relationship was assessed
nonparametrically, as previously conducted by Kelly et al.13
For this analysis, data lines were grouped into three
categories (0.1–12.0; 12.1–29.5; 29.6+ MET h/week) and
meta-analyses within these 3 PA categories were conducted.
The 3 categories refer to tertiles of data points collected from
the studies.
For each meta-analysis where the dose-response rela-
tionship is described parametrically, the same dose-
response relationship was assumed for each individual
study, and the dose-response parameter was estimated
separately for each study. The meta-analysis was then
conducted on the dose-response parameter, with an
average value of SE from the PA groups included in each
study. Using this method, results could be reported at any
value of additional PA, and we have chosen to report
results for an increase of 11.25 MET h/week—equivalent
to moving from inactive behavior to achieving international
PA recommendations. The reported results using the
primary outcome measures can also be used to determine
the modeled association between PA and the health
outcome at any level of PA using a method described in
Table 1.
Random-effects meta-analyses were performed, because
of the high degree of heterogeneity in the populations under
investigation and follow-up time.17 The heterogeneity between
studies in the meta-analyses was assessed using the I2
statistic. For each health outcome, 2 sets of meta-analyses
were conducted using Stata software (version 12; StataCorp
LP, College Station, TX): (1) with RRs adjusted for body
weight, including all identiﬁed studies (primary outcome); (2)
with RRs not adjusted for body weight, including only studies
where RRs were also available without adjustment for body
weight. Here, “RRs adjusted for body weight” were taken from
the fully adjusted models reported in the included studies, and
“RRs not adjusted for body weight” were taken from the
models adjusting for the most covariates without inclusion of
a measure of body weight. Funnel plots were analyzed to
assess the possibility of small-study or publication bias. A
sensitivity analysis was conducted by restricting results to
studies that achieved at least 6 of the 8 quality criteria.
Metaregression was performed to explore whether hetero-
geneity in the results could be explained by study-level
variables, including achievement of each of the 8 quality
criteria, the sex of participants, mean age of participants,
presence of active travel, recreational, occupational, and
household domains in the PA measurement, mean follow-up
years, and geography.
Review Registration
The protocol was registered with the PROSPERO database:
CRD42014009655.
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Ethical approval/institutional review board approval was
not required.
Results
The initial literature searches produced 16 628 titles. After a
review of the titles and abstracts, 329 articles were reviewed
in full, as detailed in the study ﬂow chart (Figure 1). An
additional 8 studies were identiﬁed by scanning reference
lists of the included studies. The majority of the excluded
studies only measured 1 domain of PA or did not adjust for
any measure of obesity. Thirty-six studies were included in the
ﬁnal review (listed in Table S3), of which 33 contributed to
CVD meta-analyses and 3 contributed to the T2DM meta-
analyses.
Table 2 provides a summary of the results of the meta-
analyses for estimates both with and without adjustment for
body weight and also displays the total number of data points
and incidents for each disease outcome. Five data points had
to be excluded from meta-analyses because they pertained to
conditions for which we only had 1 result, such as Wattanakit
et al.,18 which was the only study to report the PA effect on
venous thromboembolism incidence. These studies are listed
in Table S4. In addition, 3 studies were removed in the review
stage because of overlapping cohorts.
More speciﬁcally, Figure 2 graphically outlines RR results
for the CVD mortality studies plotted against the amount of
PA in our standardized metric.
The 0.25 power transformation is chosen as the preferred
transform in this article because demonstrates a better ﬁt to
the data; the r2 value for this transformation was 0.75
compared to 0.29 for the log linear transformation. In terms
of the dose-response relationship, the incremental change in
risk for 3 differing intensities of PA (low, medium, and high)
are listed in Table 3. In general, we noted that the greatest
rate of reduction occurs in the ﬁrst category, that is, as you
move from low to medium amounts of PA rather than from
medium to high.
Cardiovascular Disease Meta-Analyses
The 33 studies included in the CVD meta-analyses were
conducted in Europe (n=13), the United States (n=13), and
the rest of the world (n=7). They included a total of
1 683 693 participants, with 89 493 events occurring during
an average follow-up period of 12.8 years. The number of data
points pooled for each health outcome was as follows: 5 for
CVD incidence, 14 for CVD mortality, and 9 for stroke
incidence; 6 for CHD incidence, 2 for CHD mortality, 5 for
heart failure incidence, and 2 for MI incidence.
Increasing PA by 11.25 MET h/week was associated
with a signiﬁcant decrease in risk for all of the cardiovas-
cular outcomes. The protective association for CVD mor-
tality (RR, 0.77) was greater than for CVD incidence (RR,
0.83), a result that was also shown when restricting both
meta-analyses to studies that reported results for both CVD
mortality and incidence. Figure 3 displays the meta-analysis
of the effect of PA on CVD mortality after adjustment for
body weight for the included studies. The meta-analyses for
the remaining conditions are shown in Figures S1 through
S7.
The results that were adjusted for body weight were only
slightly attenuated in comparison with the results that were
not adjusted for body weight. The greatest effect of body
weight adjustment was noted in the RR of CVD mortality,
which reduced from 0.66 (unadjusted) to 0.77 (adjusted for
body weight).
The meta-analysis results for the various subcategories of
CVD outcomes (such as MI incidence) showed that the
estimated RRs were very similar to CVD as a whole. The 0.25
power transformation for overall CVD incidence was 0.83,
versus 0.82 for stroke incidence, 0.80 for CHD incidence,
0.81 for heart failure incidence, and 0.75 for MI incidence.
The dose-response graphs (Figures S8 and S9) show that the
greatest risk reduction was observed when moving from
Table 1. Deriving a Modeled Estimate of the Association
Between PA and Health Outcomes at Any Level of PA Using
the Results From These Meta-Analyses
The results reported in this article (displayed in Table 4) collapse the
modeled relationship between PA and health outcomes across a
continuous PA metric to a single parameter in order to provide
comparable results across disease outcomes. These parameters can be
used to estimate the modeled association between PA and health
outcome for the difference between any two levels of PA. For example,
the meta-analysis of CVD incidence using an Additional or Marginal
METs approach suggests that the RR for a change from 0 MET h/day to
1.61 MET h/day (equivalent to 11.25 MET h/week) is 0.83. These
values can be put into equation (1) to obtain the estimate b=0.15.
RR ¼ 1þ b MET hr/day0:25 (1)
This can then be used to estimate the RR for a unit increase of MET
h/day at any PA level. For example, the RR of CVD incidence associated
with a change from 2 to 5 MET h/day is estimated as follows:
RR2 ¼ 1 0:15 20:25 ¼ 0:82
RR5 ¼ 1 0:15 50:25 ¼ 0:77
RR2!5 ¼ RR5RR2 ¼ 0:94
CVD indicates cardiovascular disease; MET, metabolic equivalent of task; PA, physical
activity; RR, relative risk.
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inactive to moderate PA. Therefore, one can extrapolate that
the greatest beneﬁt may be derived from an additional
6 MET h/week, with a risk reduction of 4.3% per MET h/
week for CVD mortality and 1.7% for CVD incidence,
respectively.
Type 2 Diabetes Mellitus
Three studies were identiﬁed with incidence of T2DM as an
outcome variable. These 3 studies were conducted in the UK,
United States, and China, respectively. They included a total
of 261 618 participants and 19 417 events occurring during
an average follow-up period of 7.5 years.
The meta-analysis found a 0.74 RR (95% CI, 0.77–0.72) for
T2DM after adjustment for body weight and a marginally
greater reduction in risk inmodels not adjusted for body weight.
The dose-response curve shown in Figure S10 demon-
strates that the largest beneﬁt may be derived when moving
from inactive (0 METs) to 6 METs (RR, 0.77), compared with
0.74 in response to 11.25 MET h/week of PA as per current
guidelines.
Sensitivity Analysis
For T2DM, CVD mortality, and CVD incidence, the results of
the meta-analysis were robust to the method of parameter-
izing the dose-response relationship (Table 4). In general, the
results obtained using the selected 0.25 transformation were
similar to those obtained using other transformation for each
of the disease outcomes, including both linear and log linear
relationships. For CVD incidence, CVD mortality, stroke
incidence, CHD incidence, CHD mortality, heart failure
incidence, and MI incidence, the 0.25 power transformation
produced the result furthest from the null hypothesis. For
instance, in estimating the RR of CVD incidence for an
Literature search using PubMed & Embase
n = 16,628
Titles screened n= 14,995
Abstracts screened n = 1,130
Conference titles removed 1,673
Full papers screened n = 329
Excluded abstracts at screening 801
Outcome not relevant (n=119)
Review (n=131)
Cohort not free of confounding factors 
at baseline (e.g. smokers or cancer 
patients) (n=75)
Exposure not relevant (n=169)
Fitness rather than PA measured (n=67)
Commentary (n=43)
Cross-sectional analysis (n=36)
Randomised Controlled Trial (n=89)
Editorial (n=28)
Language/no abstract (n=19)
Case control (n=17)
Duplicates (n=8)
Studies included in main analysis n = 36
Diabetes 
Incidence  
n= 3
CVD 
Outcome 
n=33
Excluded based on title 13,865
Figure 1. Flow chart for inclusion of studies. CVD indicates cardiovascular disease; diabetes, diabetes
mellitus.
DOI: 10.1161/JAHA.115.002495 Journal of the American Heart Association 5
Physical Activity vs Cardiovascular Disease Wahid et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
D
ow
nloaded from
 http://ahajournals.org by on March 25, 2019
11.25 MET h/week, increase in PA ranged from 0.83 (0.25
power transformation), versus RR 0.89 (0.75 power transfor-
mation) and 0.92 (linear transformation).
Uniquely, however, for T2DM incidence, the 0.25 power
transformation produced a lower RR estimate as compared
with the other transformations. For 0.25, the RR was 0.74,
compared with a RR of 0.70 for the 0.75 transform and 0.68
for the linear relationship.
Estimates of relative risk for CHD incidence and heart failure
incidence were more sensitive to the choice of
parameterization, with results for CHD incidence ranging from
RR 0.80 (0.25 power transformation) to 0.90 (linear relation-
ship).
Table S5 demonstrates the effects of limiting the meta-
analyses to those studies that achieved at least 6 of the 8
quality criteria. This restrictionmade very little difference to the
results, with a slight increase in the observed RR reduction
associated with an 11.25 MET h/week increase in PA for the
vast majority of disease outcomes. Interestingly, for CHD
incidence, the RR reduction attenuated slightly from 0.23 to
0.19 when including only the higher-quality studies. As
expected, however, there was some sensitivity when the quality
criterion was used as a continuous measure, in that the very-
low-quality studies overestimated the impact of PA on health.
A further sensitivity analysis was conducted to exclude
studies with PA levels that were deemed implausible (ie, PA
levels that were excessively high or low). The thresholds for
implausibility were PA levels exceeding 10 times the recom-
mendations, or lower than 30 minutes of PA per week,
respectively (a level too low to be accurately measured by
questionnaire). For CVD mortality, only 3 of 17 studies
exceeded the maximum threshold, and only 1 study was
under the minimum threshold (ie, recommended PA levels of
11.25 METs; Figure S11). However, Table S5 demonstrates
that repeating the analysis without these implausible studies
made negligible difference to the overall results. The highest
level of PA in most CVD studies was around 2 to 3 times the
recommended 11.25 MET h/week (Figure S12). The T2DM
studies all had plausible PA-level ranges, as demonstrated in
Figure S13. The highest exposure category had PA levels
varying from 8.25 to 13.8 METs, corresponding well to the
recommended PA levels of 11.25 METs/week.
Table 2. Meta-Analysis Results for Effect of Increase in Physical Activity Equivalent to Moving From Inactivity to Achieving Current
Recommendations (11.25 MET h/week, for CVD Incidence and Mortality and T2DM Incidence—Assuming a 0.25 Power
Transformation
Condition (ICD-10 Code) No. of Contributing Studies Total No. of Events
Adjusted for Body Weight Not Adjusted for Body Weight
RR (95% CI) I2 RR (95% CI) I2
CVD incidence (I00–I99) 5 6945 0.83 (0.77, 0.89) 0.0% 0.79 (0.72, 0.87) 33.3%
CVD mortality (I00–I99) 14 39 708 0.77 (0.71, 0.84) 73.6% 0.66 (0.52, 0.84) 93.6%
Stroke incidence (I60–I69) 9 13 599 0.82 (0.77, 0.87) 0.0% 0.78 (0.69, 0.88) 3.1%
CHD incidence (I20–I25) 6 12 655 0.80 (0.75, 0.86) 0.0% 0.77 (0.71, 0.83) 0.0%
CHD mortality (I20–25) 2 1022 0.80 (0.58, 1.09) 59.1% n/a n/a
Heart failure incidence (I50) 5 9457 0.81 (0.76, 0.86) 0.0% 0.75 (0.69, 0.82) 0.0%
MI incidence (I21–22) 2 6445 0.75 (0.62, 0.89) 0.0% n/a n/a
T2DM incidence (E11) 3 19 417 0.74 (0.72, 0.77) 0.0% 0.73 (0.68, 0.79) 56.0%
The various power transformations, namely, both linear and log linear associations, as well as power transformations of 0.25, 0.375, 0.50, and 0.75, are presented in Table 4 for the
various outcomes. CHD indicates coronary heart disease; CVD, cardiovascular disease; ICD, International Classiﬁcation of Disease; MI, myocardial infarction; RR, relative risk; n/a, too few
studies for a meta-analysis; T2DM, type 2 diabetes mellitus.
.4
.6
.8
1
1.2
1.4
0 10 20 30 40
Additional MET hours per day
RR, weighted by 1/SE
Loglinear, r2=0.29
Linear, r2=0.29
0.25 power, r2=0.75
0.375 power, r2=0.65
0.5 power, r2=0.55
0.75 power, r2=0.39
Figure 2. Relative risk for CVD mortality against MET hours per
day. Results from 14 studies, including the 0.25 power transfor-
mation ﬁt line as well as linear, log-linear, 0.375, 0.5, and 0.750
power transformations. Relative risk estimates are weighted by the
inverse of the reported SE, with larger circles for results with
greater weighting. The red line represents a log-linear transforma-
tion, and the orange line represents a 0.25 power transformation.
CVD indicates cardiovascular disease; MET, metabolic equivalent of
task; RR, relative risk.
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Heterogeneity and Assessment of Bias
Heterogeneity was demonstrated through the I2 statistics and
examination of both the forest and funnel plots. Table 2
demonstrated signiﬁcant heterogeneity in the study results
for CVD and CHD mortality, which may well be a consequence
of the varying populations with differing baseline measures of
PA and varying methods of measurement. Of note, however,
inclusion of body-weight–adjusted studies did reduce the I2
statistics throughout.
Table 3. Categorical Analyses of Dose-Response Relationship of Physical Activity on CVD and T2DM, Compared to Baseline of
Inactive Behaviour
Health Outcome
Low Physical Activity
(0.1–11.5 METs h/week)
Medium Physical Activity
(11.5–29.5 METs h/week)
High Physical Activity
(29.5+ METs h/week)
CVD incidence (I00–I99) 0.89 (0.82, 0.98) 0.79 (0.69, 0.89) 0.75 (0.64, 0.87)
CVD mortality (I00–I99) 0.72 (0.67, 0.77) 0.72 (0.66, 0.78) 0.73 (0.67, 0.79)
Stroke incidence (I60–I69) 0.85 (0.80, 0.91) 0.81 (0.74, 0.88) 0.76 (0.68, 0.85)
CHD incidence (I20–I25) 0.87 (0.80, 0.95) 0.78 (0.74, 0.82) 0.70 (0.66, 0.75)
CHD mortality (I20–25) N/A 0.76 (0.63, 0.93) N/A
Heart failure incidence (I50) N/A 0.79 (0.72, 0.85) 0.74 (0.68, 0.79)
MI incidence (I21–22) N/A 0.76 (0.66, 0.87) N/A
T2DM incidence (E11) 0.77 (0.74, 0.80) 0.70 (0.54, 0.90) N/A
CHD indicates coronary heart disease; CVD, cardiovascular disease; MET, metabolic equivalent of task; MI, myocardial infarction; N/A, not available; T2DM, type 2 diabetes mellitus.
NOTE: Weights are from random effects analysis
Overall  (I−squared = 91.3%, p = 0.000)
JAAC, women, 40−79
SMCS, men, 40−59
ID
NWHS, adults
KEPEC, women, 65+
Framingham, women, 75+
Study
CCHS, women, 25−66
Framingham, men, 75+
JAAC, men, 40−79
MONICA, adults, 25−64
NHS, women, 30−55
CHS, men, 65+
SMHS, men, 40−74
EPIC, adults, 25−70
SOF, women, 65+
SCHS, adults, 45−74
CCHS, men, 25−66
HSE/SHS, adults, 40+
0.77 (0.71, 0.84)
0.88 (0.79, 0.97)
0.87 (0.67, 1.13)
RR (95% CI)
0.79 (0.71, 0.87)
0.80 (0.68, 0.94)
0.51 (0.30, 0.87)
0.87 (0.79, 0.95)
0.79 (0.36, 1.72)
0.86 (0.78, 0.95)
0.72 (0.56, 0.91)
0.71 (0.65, 0.78)
0.71 (0.66, 0.76)
0.84 (0.74, 0.97)
0.86 (0.82, 0.90)
0.64 (0.58, 0.71)
0.85 (0.79, 0.92)
0.86 (0.80, 0.91)
0.53 (0.50, 0.57)
100.00
6.70
4.31
Weight
6.68
5.90
1.88
%
6.89
1.00
6.73
4.58
6.82
7.02
6.22
7.30
6.79
6.99
7.12
7.08
1.5 2
 Relative risk for CVD mortality of increase of 11.25 MET h/w
Figure 3. Meta-analysis of 11.25 MET h/week increase in physical activity on CVD mortality, with a 0.25
power transformation, adjusted for body weight. CVD indicates cardiovascular disease; MET, metabolic
equivalent of task; RR, relative risk.
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Examination of the forest plot for CVD mortality (Figure 3)
revealed that both the Framingham19 and the Health Survey
for England20 studies showed considerably larger effect sizes
than the remaining studies. Metaregression was conducted to
explore possible explanations of this heterogeneity.
Meta-Regression
Table S6 shows the effects of moderator variables on the RR
of CVD mortality. First, there was an association between
quality of study and effect size, with a metaregression
coefﬁcient of 0.07 per quality score point. In addition, it was
noted that studies that measure body weight using subjective
measurements estimate a 0.24 lower RR as compared with
those that use objective measurements. In assessing the
effects of geographical location, US cohort studies estimated
an RR further from the null hypothesis, with a difference of
0.15, as compared with studies conducted elsewhere.
Small Study Bias or Publication Bias
Small study effects, or publication bias, was assessed
through visual inspection of the funnel plots, as shown in
Figure 4 for CVD mortality (the remaining conditions dis-
played in Figures S14 through S20). In general, the plots
were highly symmetrical, showing little signs of publication
bias. In certain disease outcomes, the smaller, less-powerful
studies often overestimated the effects of PA. For example,
in CVD incidence, the Framingham male cohort, which
contributed a mere 0.4% weighting provided an RR estimate
of 0.53 as compared with the overall estimated relative of
CVD incidence of 0.83.
In contrast, however, for CHD incidence, the smallest study
reported an increase in disease outcome for increasing PA
levels. The Belstress men’s cohort,21 which was afforded a
weighting of 0.50% reported an RR of 1.12 compared with the
overall RR estimate of 0.80 for CHD incidence. These data
points highlighted the effect of small study bias, which could
be attributed to clinical or methodological diversity.
Discussion
We found a decrease in the risk of all cardiovascular
outcomes and diabetes mellitus incidence with increasing
levels of PA. These RRs were only marginally attenuated when
adjusting for a measure of body weight, suggesting that the
majority of the health beneﬁt that accrues from increasing PA
is mediated by mechanisms beyond weight maintenance. Our
ﬁndings suggest that an increase in 11.25 MET h/week for
an inactive individual is associated with a reduction of risk for
cardiovascular mortality by 23% and diabetes mellitus
incidence by 26%, independent of body weight. This may
Table 4. Meta-Analysis Results for 11.25 MET h/week Increase on CVD and T2DM: Sensitivity to Transformation Assumptions
Health Outcome (ICD-10 Code)
RR for 11.25 MET h/week Increase in PA, With 95% CIs
0.25 Power 0.375 Power 0.5 Power 0.75 Power Linear Log Linear
CVD incidence (I00–I99) 0.83 (0.77, 0.89) 0.85 (0.79, 0.91) 0.86 (0.80, 0.92) 0.89 (0.83, 0.96) 0.92 (0.86, 0.98) 0.91 (0.85, 0.97)
CVD mortality (I00–I99) 0.77 (0.71, 0.84) 0.78 (0.70, 0.87) 0.79 (0.70, 0.90) 0.80 (0.67, 0.95) 0.80 (0.63, 1.01) 0.82 (0.70, 0.95)
Stroke incidence (I60–I69) 0.82 (0.77, 0.87) 0.82 (0.77, 0.87) 0.82 (0.77, 0.88) 0.84 (0.77, 0.91) 0.85 (0.77, 0.94) 0.85 (0.77, 0.93)
CHD incidence (I20–I25) 0.80 (0.75, 0.86) 0.82 (0.77, 0.88) 0.84 (0.79, 0.90) 0.88 (0.82, 0.93) 0.90 (0.85, 0.96) 0.89 (0.84, 0.95)
CHD mortality (I20–25) 0.80 (0.58, 1.09) 0.81 (0.61, 1.08) 0.82 (0.63, 1.07) 0.84 (0.67, 1.05) 0.86 (0.70, 1.05) 0.85 (0.68, 1.06)
Heart failure incidence (I50) 0.81 (0.76, 0.86) 0.83 (0.79, 0.89) 0.86 (0.81, 0.91) 0.89 (0.84, 0.95) 0.92 (0.87, 0.98) 0.91 (0.86, 0.97)
MI incidence (I21–22) 0.75 (0.62, 0.89) 0.76 (0.63, 0.91) 0.77 (0.65, 0.93) 0.81 (0.67, 0.97) 0.84 (0.70, 1.00) 0.83 (0.69, 0.99)
T2DM incidence (E11) 0.74 (0.72, 0.77) 0.73 (0.71, 0.76) 0.72 (0.70, 0.75) 0.70 (0.68, 0.72) 0.68 (0.66, 0.70) 0.69 (0.67, 0.71)
CHD indicates coronary heart disease; CVD, cardiovascular disease; ICD, International Classiﬁcation of Disease; MET, metabolic equivalent of task; MI, myocardial infarction; PA, physical
activity; RR, relative risk; T2DM, type 2 diabetes mellitus.
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Relative risk for increase of 11.25 MET h/w
Funnel plot with pseudo 95% CIs: CVD mortality
Figure 4. Funnel plot for meta-analyses of 11.25 MET h/week
increase in physical activity, with a 0.25 power transformation, for
CVD mortality, adjusted for body weight. CVD indicates cardio-
vascular disease; MET, metabolic equivalent of task.
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provide greater effect sizes compared to more-recent studies,
such as Arem et al.,22 who used a value of 7.5 MET h/week;
however, the key beneﬁt of this article is that the results can
be generated for an MET value, including 7.5 to provide a
direct comparison.
Strengths and Weaknesses
This is the ﬁrst meta-analysis to assess the effect of PA on
CVD and diabetes mellitus using a continuous index of PA,
thereby allowing for direct comparison of results across
studies with heterogeneous data collection methods. Previous
meta-analyses that have considered the effect of PA on health
outcomes have mostly used categorical measures of PA (eg,
high vs moderate vs low).23–25 Those that used a single
continuous comparable index of PA have not considered
multiple health outcomes.10,26–28 This study is the ﬁrst to
consider a range of CVDs simultaneously, allowing for
comparable results across these disease boundaries.
The results of these meta-analyses, which can be used to
estimate the risk reduction associatedwith a unit increase of PA
at any PA level, are vital for an accurate assessment of the
population burden of physical inactivity. A recent study
estimated the global burden of physical inactivity and con-
cluded that the population health burden associated with
physical inactivity was of an equivalent size to that associated
with smoking.29 However, this analysis has been criticized for
overestimating the burden of PA,30 given that the researchers
derived their population impact fractions (PIFs) for physical
inactivity from RRs drawn from meta-analyses that either
compare pooled estimates of “low” PA with “high” PA, or
compare inactive behavior with meeting PA recommendations
(although other assumptions by the authors are likely to result
in underestimation).29 The appropriate RRs for such PIFs should
compare PA at the average level within the inactive population
with the level required tomeet recommendations. SuchRRs can
only be derived from analyses similar to those reported here,
which account for the continuous nature of the PA variable.
Our results supported the assumption of other meta-
analysis that the inactive have most to gain by any increase in
PA. The relationship between PA and health outcomes is such
that a small increase from inactive behavior provides most of
the beneﬁt, and subsequent increases produce diminishing
returns. This is supported by 2 previous meta-analyses that
assessed the dose-response relationship between PA and
coronary heart disease26 and all-cause mortality.10 The
Woodcock meta-analysis suggested that a ﬁrst-degree frac-
tional polynomial with 0.25 power (as has been used in this
study) provides the best ﬁt to the data.10 However, a
drawback of using such a transformation is that it is
necessary to set a somewhat arbitrary “zero” level of PA.
We assumed that the reference group from each of the
studies achieved zero PA (ie, they were considered to be
inactive), but the actual PA level in these groups will vary
between studies. The fact that the included studies tended to
show the same “diminishing returns” relationship with PA
suggests that the levels of PA in the reference groups were
fairly similar and approximately sedentary. However, this
diminishing returns relationship could be evidence of a
general bias present in the studies inﬂating the risk of
disease in the PA reference groups. We explored the effect on
meta-analysis results of method of parameterizing the dose-
response relationship and also compared results with non-
parametric categorical analyses and, in most cases, found
that the results were robust to choice of method.
A limitation of using the comparable index of PA is that it
does not distinguish between sustained periods of moderate
activity and short periods of vigorous activity, which may have
differing effects on health. Also, the PA recommendations6
advise either 150 minutes of moderate-to-vigorous activity
(150 MVPA) or 75 minutes of vigorous physical activity
(75 VPA), whereas in this analysis we have focused on the
more commonly used 150 MVPA. Therefore, our results pertain
to 11.25 MET h/week, whereas for 75 VPA (with 6.5 METs for
vigorous activity), the results would be presented for
9.75 MET h/week; therefore, this would attenuate the RR
estimates. With respect to the search strategy, the potential of
introducing bias into the review process by use of a single
reviewer for reviewing full-text articles and for the data
extraction process cannot be excluded, although a second
reviewer cross-checked undecided cases and a 10% sample
was checked by another reviewer at each stage of assessment.
The aim of this article was to explore the effect of total PA,
expressed as metabolic expenditure, as opposed to domain-
speciﬁc investigation. In reality, although many studies use a
combination of domains to estimate total PA, they rarely truly
include measurement of total PA exposure. We decided to
include studies that had assessed 2 or more (of the 4 main)
domains because this is likely to represent a reasonable
minimum to be able to assess a meaningful proportion of
overall PA exposure.
The studies included in this systematic review were mostly
of high quality, notwithstanding the variability in PA measures.
The prospective cohort study design provides some protec-
tion against recall or selection bias. There were few issues
with loss to follow-up or with detection of events. However,
the measures of PA used in the studies were heterogeneous,
both in terms of the measurement tools and in the aspects of
PA that were being measured. As a result, the derivation of
the comparable index of PA was challenging and is likely to
have included some misclassiﬁcation bias, because we were
forced to make assumptions about behavior and activity levels
that were not reported in the studies. Usually, misclassiﬁca-
tion bias would result in an underestimate of effect size, but
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here it may have led to a reduction in variance in PA levels,
which will have led to a general bias away from the null
hypothesis for the studies included in the meta-analysis.
It has previously been noted that studies of the effect of PA
on health would beneﬁt from improved measures of non-
leisure time PA, particularly for studying the effect in women
where levels of recreational activity are lower.24 The use of
self-reported PA questionnaires in all of the included studies is
problematic, given that self-reported PA has been shown to
have a low-to-moderate correlation with objective mea-
sures.31 Furthermore, whereas all of the studies used healthy
participants, only half included a “burn-out” period to reduce
the risk of reverse causation. The lack of availability of studies
conducted in low- and middle-income countries precludes our
ability to assess the impact of increasing PA levels in these
settings, where the burden of physical inactivity and non-
communicable diseases is also high. Given that all of the
studies included in the meta-analysis were observational, the
potential for residual confounding from imprecise or unmea-
sured factors cannot be excluded from pooling. Although all of
the studies adjusted for multiple potential confounding
variables, not all confounders were adjusted for in every
study. Similarly, all of the results included in the meta-analysis
were based on analyses using measures of PA and body
weight made at only 1 time point, which is likely to result in
underestimates of the effect of PA on health.
Comparison With Other Studies
Three other reviews investigating the effects of PA on CVD are
summarized in Table 5.11,22–24,32
Each review had different objectives and used different
methods both to identify studies and combine results. The
majority have chosen to combine risk estimates based on
categorical measures of the exposure variable. We believe
that our point estimates for the RR associated with CVD
outcomes (increasing PA by 11.25 MET h/week) correspond
most closely with comparisons between moderate and low
levels of PA. Our estimated RR of 0.83 for congestive heart
disease incidence is similar to estimates from meta-analyses
by Soﬁ et al.33 and Oguma et al.,23 whereas our estimate for
stroke incidence is of greater magnitude than that by Diep
et al.24 Our estimate for T2DM incidence is similar to that
produced by Jeon et al.11
Our study results for CVD mortality also proved similar to
Arem et al.,22 which fell outside our search dates but was
added later at the review stage. Arem et al. studied the
effects of leisure time PA on all-cause and also CVD mortality
and found a CVD mortality hazard ratio of 0.80 between 0.1
and 7.5 METs and 0.67 corresponding to 7.5 to 15 METs of
leisure time PA. These estimates correspond extremely well
with our estimates for CVD mortality at 11.25 METs, although
the main focus of the Arem et al. article was to explore the
potentially harmful effects of extremely high PA levels, up to
75 MET h/week.
Conclusions
This meta-analysis has provided an assessment of the health
beneﬁts for a unit increase in PA levels, both before and after
adjustment for body weight. The methods used here enable
direct comparison of the effect of PA on a range of CVDs and
diabetes mellitus.
Future studies should investigate the effect of increasing
PA levels in low- and middle-income countries. Further
analysis of the effect of increasing PA on other health
Table 5. Comparison With Results From Other Meta-Analyses of the Effect of Physical Activity on CVD Outcomes Reported in
Peer-Reviewed Journals
Citation Health Outcome Physical Activity Comparison
Relative
Risk 95% CI
Studies Included
in Meta-Analysis Additional Notes
Oguma et al. (2004)23 CHD (incidence
or mortality)
Categorical: moderate vs low 0.77 0.64 to 0.92 2 Includes case-control
studies and
retrospective
cohort studies
Categorical: high vs low 0.57 0.41 to 0.79
Sofi et al. (2008)33 CHD (incidence
or mortality)
Categorical: moderate vs low 0.88 0.83 to 0.93 22 Leisure time PA only
Categorical: high vs low 0.73 0.66 to 0.80
Diep et al. (2010)24 Stroke (incidence
or mortality)
Categorical: high vs
moderate vs low
0.81
0.89
0.75 to 0.87
0.86 to 0.93
13
Jeon et al. (2007)11 T2DM incidence Categorical: moderate vs
sedentary
0.69 0.58 to 83 5 Not adjusted for
body weight
Arem et al. (2015)22 CVD mortality Categorial: low (0.1–7.5 METs) 0.80 0.77 to 0.84 6 Adjusted for
body weightCategorial: low (0.1–7.5 METs) 0.67 0.65 to 0.80
CHD indicates coronary heart disease; CVD, cardiovascular disease; MET, metabolic equivalent of task; PA, physical activity; T2DM, type 2 diabetes mellitus.
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behaviors, such as diet and smoking, and an analysis of the
potential differences that may arise with age, ethnicity, and
socioeconomic status, for example, is also warranted. This
meta-analysis provides clear direction for policy makers that
there may be greater gains for population health by targeting
those who do very little PA. However, population-level
approaches to improving PA are still likely to be effective at
reducing the health burden attributed to physical inactivity if
the protective effect of PA on health is observed at high as
well as low PA levels.
Sources of Funding
This review was funded by the British Heart Foundation (Grant
No. 021/P&C/Core/2010/HPRG). The funders had no role in
study design, data collection and analysis, decision to publish,
or preparation of the manuscript. Nichols is supported by
funding from the National Heart Foundation of Australia and
Deakin University for the Australian Heart Disease Statistics
Project.
Disclosures
None.
References
1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M,
Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN,
Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F,
Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG,
Brunekreef B, Bryan-Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT,
Byers TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, Chen H,
Chen JS, Cheng AT, Child JC, Cohen A, Colson KE, Cowie BC, Darby S,
Darling S, Davis A, Degenhardt L, Dentener F, Des Jarlais DC, Devries K,
Dherani M, Ding EL, Dorsey ER, Driscoll T, Edmond K, Ali SE, Engell RE, Erwin
PJ, Fahimi S, Falder G, Farzadfar F, Ferrari A, Finucane MM, Flaxman S,
Fowkes FG, Freedman G, Freeman MK, Gakidou E, Ghosh S, Giovannucci E,
Gmel G, Graham K, Grainger R, Grant B, Gunnell D, Gutierrez HR, Hall W,
Hoek HW, Hogan A, Hosgood HD III, Hoy D, Hu H, Hubbell BJ, Hutchings SJ,
Ibeanusi SE, Jacklyn GL, Jasrasaria R, Jonas JB, Kan H, Kanis JA, Kassebaum
N, Kawakami N, Khang YH, Khatibzadeh S, Khoo JP, Kok C, Laden F, Lalloo R,
Lan Q, Lathlean T, Leasher JL, Leigh J, Li Y, Lin JK, Lipshultz SE, London S,
Lozano R, Lu Y, Mak J, Malekzadeh R, Mallinger L, Marcenes W, March L,
Marks R, Martin R, McGale P, McGrath J, Mehta S, Mensah GA, Merriman TR,
Micha R, Michaud C, Mishra V, Mohd Hanaﬁah K, Mokdad AA, Morawska L,
Mozaffarian D, Murphy T, Naghavi M, Neal B, Nelson PK, Nolla JM, Norman R,
Olives C, Omer SB, Orchard J, Osborne R, Ostro B, Page A, Pandey KD, Parry
CD, Passmore E, Patra J, Pearce N, Pelizzari PM, Petzold M, Phillips MR, Pope
D, Pope CA III, Powles J, Rao M, Razavi H, Rehfuess EA, Rehm JT, Ritz B,
Rivara FP, Roberts T, Robinson C, Rodriguez-Portales JA, Romieu I, Room R,
Rosenfeld LC, Roy A, Rushton L, Salomon JA, Sampson U, Sanchez-Riera L,
Sanman E, Sapkota A, Seedat S, Shi P, Shield K, Shivakoti R, Singh GM,
Sleet DA, Smith E, Smith KR, Stapelberg NJ, Steenland K, St€ockl H, Stovner
LJ, Straif K, Straney L, Thurston GD, Tran JH, Van Dingenen R, van Donkelaar
A, Veerman JL, Vijayakumar L, Weintraub R, Weissman MM, White RA,
Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams W, Wilson N,
Woolf AD, Yip P, Zielinski JM, Lopez AD, Murray CJ, Ezzati M, AlMazroa MA,
Memish ZA. A comparative risk assessment of burden of disease and injury
attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–
2010: a systematic analysis for the Global Burden of Disease Study 2010.
Lancet. 2012;380:2224–2260.
2. Paffenbarger RS, Hale WE. Work activity and coronary heart mortality. N Engl J
Med. 1975;292:545–550.
3. Morris JN, ed. Exercise Versus Heart Attack: History of a Hypothesis. 2nd ed.
Oxford, UK: Oxford University Press; 2005.
4. Department of Health. On the state of public health: annual report of the Chief
Medical Ofﬁcer. London: Department of Health; 2009.
5. World Health Organization (WHO). Global recommendations on physical
activity for health. Geneva, Switzerland: WHO; 2010.
6. Chief Medical Ofﬁcers of England, Scotland, Wales, and Northern Ireland. Start
active, stay active: a report on physical activity from the four home countries’
Chief Medical Ofﬁcers. London: Department of Health.
7. US Department of Health and Human Services (US DHHS). 2008 physical
activity guidelines for Americans. Washington, DC: US DHHS; 2008.
8. Lee IM, Paffenbarger RS Jr. Associations of light, moderate, and vigorous
intensity physical activity with longevity. The Harvard Alumni Health Study. Am
J Epidemiol. 2000;151:293–299.
9. Fujita K, Takahashi H, Miura C, Ohkubo T, Sato Y, Ugajin T, Kurashima K,
Tsubono Y, Tsuji I, Fukao A, Hisamichi S. Walking and mortality in Japan: the
Miyagi Cohort Study. J Epidemiol. 2004;14(suppl 1):S26–S32.
10. Woodcock J, Franco OH, Orsini N, Roberts I. Non-vigorous physical activity and
all-cause mortality: systematic review and meta-analysis of cohort studies. Int
J Epidemiol. 2011;40:121–138.
11. Jeon CY, Lokken RP, Hu FB, van Dam RM. Physical activity of moderate
intensity and risk of type 2 diabetes: a systematic review. Diabetes Care.
2007;30:744–752.
12. Wells G. The Newcastle-Ottawa Scale (NOS) for assessing the quality of
nonrandomised studies in meta-analyses. 2013. Available at: http://
www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed June 7,
2016.
13. Kelly P, Kahlmeier S, G€otschi T, Orsini N, Richards J, Roberts N, Scarborough P,
Foster C. Systematic review and meta-analysis of reduction in all-cause
mortality from walking and cycling and shape of dose response relationship.
Int J Behav Nutr Phys Act. 2014;11:132.
14. Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR Jr, Tudor-
Locke C, Greer JL, Vezina J, Whitt-Glover MC, Leon AS. 2011 Compendium of
Physical Activities: a second update of codes and MET values. Med Sci Sports
Exerc. 2011;43:1575–1581.
15. Moody A. Adult Anthropometric Measures, Overweight and Obesity. Health and
Social Care Information Centre. Health Survey for England 2013. HSCIC:
Leeds; 2015.
16. Alaike H. A new look at the statistical model identiﬁcation. IEEE Trans Automat
Contr. 1974;19:716–723.
17. Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures.
BMJ. 1997;315:1533–1537.
18. Wattanakit K, Lutsey PL, Bell EJ, Gornik H, Cushman M, Heckbert SR,
Rosamond WD, Folsom AR. Association between cardiovascular disease risk
factors and occurrence of venous thromboembolism. A time-dependent
analysis. Thromb Haemost. 2012;108:508–515.
19. Sherman SE, D’Agostino RB, Cobb JL, Kannel WB. Does exercise reduce
mortality rates in the elderly? Experience from the Framingham Heart Study.
Am Heart J. 1994;128:965–972.
20. Soedamah-Muthu SS, De Neve M, Shelton NJ, Tielemans SM, Stamatakis E.
Joint associations of alcohol consumption and physical activity with all-cause
and cardiovascular mortality. Am J Cardiol. 2013;112:380–386.
21. Clays E, De Bacquer D, Janssens H, De Clercq B, Casini A, Braeckman L,
Kittel F, De Backer G, Holtermann A. The association between leisure time
physical activity and coronary heart disease among men with different
physical work demands: a prospective cohort study. Eur J Epidemiol.
2013;28:241–247.
22. Arem H, Moore SC, Patel A, Hartge P, Berrington de Gonzalez A, Visvanathan K,
Campbell PT, FreedmanM,Weiderpass E, Adami HO, LinetMS, Lee IM,Matthews
CE. Leisure time physical activity and mortality: a detailed pooled analysis of the
dose-response relationship. JAMA Intern Med. 2015;175:959–967.
23. Oguma Y, Shinoda-Tagawa T. Physical activity decreases cardiovascular disease
risk in women: review and meta-analysis. Am J Prev Med. 2004;26:407–418.
24. Diep L, Kwagyan J, Kurantsin-Mills J, Weir R, Jayam-Trouth A. Association of
physical activity level and stroke outcomes in men and women: a meta-
analysis. J Womens Health (Larchmt). 2010;19:1815–1822.
25. Nocon M, Hiemann T, M€uller-Riemenschneider F, Thalau F, Roll S, Willich SN.
Association of physical activity with all-cause and cardiovascular mortality: a
systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil.
2008;15:239–246.
26. Sattelmair J, Pertman J, Ding EL, Kohl HW III, Haskell W, Lee IM. Dose response
between physical activity and risk of coronary heart disease: a meta-analysis.
Circulation. 2011;124:789–795.
27. Bao Y, Michaud DS. Physical activity and pancreatic cancer risk: a systematic
review. Cancer Epidemiol Biomarkers Prev. 2008;17:2671–2682.
DOI: 10.1161/JAHA.115.002495 Journal of the American Heart Association 11
Physical Activity vs Cardiovascular Disease Wahid et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
D
ow
nloaded from
 http://ahajournals.org by on March 25, 2019
28. O’Rorke MA, Cantwell MM, Cardwell CR, Mulholland HG, Murray LJ. Can
physical activity modulate pancreatic cancer risk? A systematic review and
meta-analysis. Int J Cancer. 2010;126:2957–2968.
29. Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT; Lancet
Physical Activity Series Working Group. Effect of physical inactivity on major
non-communicable diseases worldwide: an analysis of burden of disease and
life expectancy. Lancet. 2012;380:219–229.
30. Scowcroft H. Is being inactive really ‘as bad as smoking’? Science
Update Blog; 2012. Available at: http://scienceblog.cancerresearchuk.org/
2012/08/15/is-being-inactive-really-as-bad-as-smoking/. Accessed June 7,
2016.
31. Prince SA, Adamo KB, Hamel ME, Hardt J, Connor Gorber S, Tremblay M. A
comparison of direct versus self-report measures for assessing physical
activity in adults: a systematic review. Int J Behav Nutr Phys Act.
2008;5:56.
32. Soﬁ F, Valecchi D, Bacci D, Abbate R, Gensini GF, Casini A, Macchi C. Physical
activity and risk of cognitive decline: a meta-analysis of prospective studies. J
Intern Med. 2011;269:107–117.
33. Soﬁ F, Capalbo A, Cesari F, Abbate R, Gensini GF. Physical activity during
leisure time and primary prevention of coronary heart disease: an updated
meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil.
2008;15:247–257.
DOI: 10.1161/JAHA.115.002495 Journal of the American Heart Association 12
Physical Activity vs Cardiovascular Disease Wahid et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
D
ow
nloaded from
 http://ahajournals.org by on March 25, 2019
  
 
 
SUPPLEMENTAL MATERIAL  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D
ow
nloaded from
 http://ahajournals.org by on March 25, 2019
Table S1. Criteria for assessment of bias / study quality  
1st Author Year R
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Sherman(1) 1994 1 1 1 0 0 1 1 1 6 
Sesso(2)  1999 1 1 0 1 1 0 1 0 5 
Hu(3)   2000 1 1 0 0 0 1 1 1 5 
Sesso(4)   2000 1 1 0 0 0 1 1 0 4 
Gregg(5)   2003 1 1 1 1 0 1 1 0 6 
Hu (NHS)(6) 2004 1 1 0 0 0 1 1 1 5 
Hu (Finnish 
pop)(7) 
2004 
0 1 0 1 0 1 1 1 5 
Franco(8) 2005 1 1 1 0 0 1 1 0 5 
Myint(9) 2006 1 1 1 1 0 1 1 1 7 
Hu(10) 2007 0 1 0 1 0 1 1 1 5 
Hu(11) 2010 1 0 1 0 1 0 1 1 5 
Eguchi (12) 2012 1 1 1 0 0 0 1 1 5 
Odegaard(13)   2011 1 1 1 1 0 1 1 1 7 
Petersen(14)   2012 1 1 1 1 0 1 1 1 7 
Reis(15)   2011 1 1 1 0 0 0 1 0 4 
Shi(16)   2013 1 1 1 1 1 0 1 1 7 
Baceviciene(17)   2012 1 1 1 1 1 0 0 1 6 
Clays(18)   2012 1 1 1 1 0 0 1 1 6 
Holtermann(19)   2012 1 1 1 1 1 0 1 1 7 
Jefferis(20)   2012 1 1 1 1 1 0 1 1 7 
Kraigher-
Krainer(21)   
2013 1 1 0 1 0 1 1 1 
6 
Park(22)   2012 1 1 1 1 0 0 0 1 5 
Chomistek(23)   2013 1 1 0 1 0 0 1 1 5 
Gunnell(24)   2013 1 1 1 1 0 0 1 1 6 
Holtermann(25)   2013 1 1 1 1 1 0 1 1 7 
Jefferis(26)   2013 1 1 1 1 1 0 1 1 7 
Kim(27)   2013 1 1 1 1 0 0 1 1 6 
McDonnell(28)   2013 0 1 1 1 1 0 1 1 6 
Patel(29)   2013 1 1 1 1 1 0 1 0 6 
Soedamah(30)   2013 1 1 0 0 0 0 1 1 4 
Vergnaud(31)   2013 1 1 1 1 1 0 1 1 7 
Wang(32)   2013 1 1 1 1 1 0 1 1 7 
Williams(16) 2013 1 0 1 1 0 1 1 1 6 
Zhang, Q(29)   2013 1 1 1 0 1 0 1 1 6 
Zhang, Y(29)   2013 1 1 1 1 1 0 1 1 7 
Young(33)   2014 1 1 1 1 0 0 1 1 6 
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 Representativeness of cohort (0 = no description or selected group of users (e.g. nurses), 1 = 
otherwise) 
 Selection of non-exposed (0 = no description or drawn from different source than exposed, 1 
= otherwise) 
 Measurement of body weight (0 = no description or self report, 1 = otherwise) 
 Measurement of physical activity (0 = no description or non-validated self report, 1 = 
otherwise) 
 Response rate (0 = no description or less than 60%, 1 = otherwise) 
 Loss to follow-up (0 = no description or greater than 5%, 1 = otherwise) 
 Reverse causality (0 = no description or included participants with health outcome at 
baseline, 1 = otherwise)  
 Measurement of health outcome (0 = no description or incidence measured by self report of 
doctor diagnosis, 1 = otherwise) 
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 Table S2. Converting physical activity measures to a standardised metric of ‘Additional METh/d’ 
The single metric that we converted all the measures from the identified papers to was ‘Additional 
MET hours per day’ (or ‘Additional METh/d’). This measure is a comparative measure, where the 
baseline group in each paper is arbitrarily assigned the value of zero and the extra physical activity in 
the other exposure groups is estimated as the amount of time spent in physical activity multiplied by 
the intensity of the physical activity, measured in METs (or ‘metabolic equivalents’). METs are a 
standard measure used in physical activity research, which are an estimate of the intensity of 
physical activity compared to a baseline of 1 MET which is the intensity of sitting quietly. A standard 
compendium of MET values for many different activities can be found on the Compendium of 
Physical Activities Google Site.(34)  
In order to develop the ‘Additional METh/d’ metric, it is necessary to estimate the METh/d for all of 
the reported physical activities described in each paper for each of the exposure groups, and then 
subtract the baseline METh/d from each of the groups. There were a number of standard rules that 
we applied for each paper, to remove subjectivity from the process. These rules were as follows: 
1. When a paper uses a range to describe an exposure (e.g. 0-2 h/week walking) we used a 
point estimate which was the mid-point of the range. 
2. When a paper uses an open category to describe an exposure we assume that the size of 
this category is the same as the closest equivalent exposure category and then calculate the 
median. For example, if a paper categorised walking as 0-2h/week; 2-4h/week; 4+ h/week, 
then we assume that the last exposure group is 4-6h/week and use the median value of 
5h/week. 
3. When physical activity is measured in ‘occasions’ or ‘sessions’ but no time is estimated, we 
assume that each occasion or session is half an hour. 
4. When a paper describes physical activity in terms of intensity (rather than describing the 
actual activity that was performed) then we assume the following MET values: light 
intensity: 2.5 METs; moderate intensity: 4.5 METs; vigorous intensity: 6.5 METs. Ambiguous 
activities are assigned to either light, moderate or vigorous intensity levels – for example, 
‘exercise’ or ‘sport’ are both categorised as vigorous. 
5. Where the paper tries to measure amount of time spent in ‘moderate or vigorous’ physical 
activity but gives no information about the type of activity, we assume a MET value of 5.5. 
6. Often papers categorised groups using an ‘or’ function. For example, an exposure group may 
consist of individuals who walk for at least 5 hours per week or exercise for at least two 
hours per week. In these instances, we assumed that any combination of these two activities 
is equally likely. So we calculated the METh/d for someone who only walks 5 hours per 
week, for someone who only exercises for two hours a week, and for someone who both 
walks for five hours a week AND exercises for two hours a week. We then calculated the 
average of the three measures, and assigned that value to the exposure group. 
7. When a paper split groups into x-tiles of an exposure variable and provided estimates of 
mean and standard deviation of the exposure variable in the whole sample, we assumed 
that the exposure variable was log-normally distributed (unless otherwise stated in the 
paper) and then calculate the exposure variable for each of the x-tile variables from this 
assumed distribution.  
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Table S3. Identified studies evaluating the effect of physical activity on CVD outcome and Type II Diabetes Incidence with adjustment for body weight 
1st Author (year) 
Cohort 
name 
Domains of PA 
measured 
Disease outcome 
Disease 
ascertainment 
Population 
Sample 
size 
Number 
of events 
Follow-
up 
(years) 
Adjustments 
Baceviciene 
(2012)(17) 
MONICA 
Recreational;  
Active Travel; 
Household 
CVD mortality 
National 
Death Register 
Lithuanian 
adults aged 
25-64 
2,643 150 12.6 
Age, sex, education, study year, 
smoking, alcohol, BMI, 
hypertension, cholesterol, 
glucose, CHD, stroke 
Chomistek (2013)(23)  
 
WHI 
 
Recreational; 
Active Travel 
 
 
CHD incidence 
 
 
Questionnaire 
& medical 
records, 
adjudicated by 
physicians 
 
US women 
aged 50-79 
 
 
 
71,018 
 
 
2,411 
 
 
12.2 
 
 
Age, sedentary time, race, 
education, income, marital 
status, smoking, history of MI, 
depression, alcohol, sleep, total 
calories, saturated fat & fibre, 
BMI 
 
 
 
Stroke incidence 
 
 
2,050 
CVD incidence 4,235 
Clays (2012)(18)  Belstress 
Recreational; 
Occupational 
CHD incidence Not reported 
Belgian 
adults aged 
35-59 
14,337 87 3.15 
Age, educational level, 
occupational class, job strain, 
BMI, smoking, alcohol, 
diabetes, SBP, cholesterol, HDL, 
Eguchi (2012) (12) 
 
JAAC 
 
Recreational; 
Active Travel 
 
CVD mortality 
 
Death 
Certificates 
 
 
Japanese 
men aged 
40-79 
 
18,747 441 
16.5 
 
Age, hx of hypertension, hx of 
diabetes, education, 
employment, mental stress, 
seven health behaviours (fruit, 
fish, milk, exercise, BMI, 
ethanol, sleep, smoking) 
 
Japanese 
women aged 
40-79 
 
24,263 408 
Franco (2005)(8) Framingham 
Recreational; 
Active Travel; 
Household; 
Occupational 
CVD incidence 
Physician 
evaluation of 
diagnosis 
US adults 
aged 28-62, 
9,033 1,573 12.0 
Age, sex, smoking, BMI, 
hypertension, co-morbidities 
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1st Author (year) 
Cohort 
name 
Domains of PA 
measured 
Disease outcome 
Disease 
ascertainment 
Population 
Sample 
size 
Number 
of events 
Follow-
up 
(years) 
Adjustments 
Gregg (2003)(5) SOF 
Walking; 
leisure 
activities; 
sports 
CVD mortality 
Death 
certificates 
US women 
aged >65 
9,518 826 10.6 
Age, smoking, BMI, co-
morbidities 
Gunnell (2013)(24) HWSS 
Recreational; 
Active Travel 
IHD disease 
incidence 
Hospital 
records 
Australian 
adults aged 
>45 
14,890 538 3 
Age, sex, smoking, charlson 
index, LTPA, sedentary activity 
level, BMI, fruit & veg intake, 
survey year, diabetes 
hospitalisation 
Holtermann 
(2012)(19) 
 
Copenhagen 
City Heart 
Study 
 
Recreational; 
Household 
 
IHD mortality Death registry 
Danish men 
aged 40-59 
5,249 579 30 
Age, clinical factors (BMI, BP) 
Holtermann 
(2013)(25) 
 
Copenhagen 
City Heart 
Study 
 
Recreational; 
Occupational 
 
CVD mortality 
National 
Death Register 
Danish men 
aged 25-66 
 
7,411 1,945 22.4 Age, smoking, alcohol, 
cholesterol, SBP, blood 
pressure meds, diabetes, 
household income, BMI 
Danish 
women aged 
25-66 
8,916 1,814 22.4 
Hu (2000)(3) 
Nurses 
Health Study 
Walking; 
vigorous 
exercise 
activities 
Stroke incidence 
Self-report 
and health 
screening 
US women 
aged 40-65 
72,488 407 8.0 
Age, smoking, BMI, alcohol,  
menopausal status,  parental 
history of CHD, aspirin use, co-
morbidities 
Hu (2004)(6) 
Nurses 
Health Study 
Walking; 
leisure 
activities 
CVD mortality 
Death 
certificates 
US women 
aged 30-55 
116,564 2,370 24.0 
Age, BMI, smoking, alcohol, 
parental history of CHD, 
menopausal status, hormone 
use 
Hu (2004)(7) 
Finland 
population 
Occupational 
PA; leisure 
activities 
CVD incidence 
Routine 
update from 
registry 
 
Finnish 
adults aged 
25-64 
18,892 818 9.8 
Age, education, alcohol, 
smoking, BMI, SBP, cholesterol, 
co-morbidities 
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1st Author (year) 
Cohort 
name 
Domains of PA 
measured 
Disease outcome 
Disease 
ascertainment 
Population 
Sample 
size 
Number 
of events 
Follow-
up 
(years) 
Adjustments 
Hu (2007)(10) 
Finland 
population 
Occupational 
PA; active 
travel; leisure 
activities 
CHD incidence 
Routine 
update from 
registry 
Finnish 
adults aged 
25-64 
47,840 4,660 18.9 
Age, education, alcohol, 
smoking, BMI, SBP, cholesterol, 
diabetes 
Hu (2010)(11) 
Finland 
population 
Occupational 
PA; active 
travel; leisure 
activities 
Heart Failure 
incidence 
Routine 
update from 
registry 
Finnish 
adults aged 
25-74 
59,178  3,614  18.4 
Age, education, alcohol, 
smoking, BMI, SBP, cholesterol, 
co-morbidities 
Jefferis (2012)(20) BRHS 
Recreational; 
Active Travel; 
Household 
Type II Diabetes 
incidence 
Self report, 
then 
corresponden
ce with 
primary care 
UK men aged 
60-79 
2,675 113 7.1 
Age, region, social class, 
smoking, alcohol, coffee, total 
kcal/day, dietary intake, 
cholesterol. BMI 
Jefferis (2013)(35)  BRHS 
Recreational; 
Household; 
Active Travel 
Stroke incidence 
NHS central 
registers & 
death 
certificates 
UK men aged 
40-59 
3,435 195 10.9 
Age, region, alcohol, smoking, 
social class, cholesterol, SBP, 
BMI, AF, LVH 
Kim (2013)(27) 
Seoul Male 
Cohort 
Study 
Recreational; 
Active Travel; 
Household; 
Occupational 
CVD mortality 
Mortality 
microdata by 
National stats 
office 
Korean 
adults aged 
40-59 
12,538 171 19 
Age, educational attainment, 
alcohol, sleep, FHx of CVD, 
smoking, BMI, health score, 
cholesterol, blood pressure, 
glucose 
Kraigher-Krainer 
(2013)(21) 
Framingham 
Recreational; 
Occupational 
Heart Failure 
Incidence 
Review of 
medical 
records & 
adjudicated by 
physician 
panel 
US adults 
aged 30-62 
1,142 250 10 
Age, sex, SBP, Hypertension, 
diabetes, valve disease, alcohol, 
LV hypertrophy, BMI 
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1st Author (year) 
Cohort 
name 
Domains of PA 
measured 
Disease outcome 
Disease 
ascertainment 
Population 
Sample 
size 
Number 
of events 
Follow-
up 
(years) 
Adjustments 
McDonnell 
(2013)(28) 
REGARDS 
Recreational; 
Occupational; 
Active Travel 
Stroke incidence 
Patients, 
medical 
records and 
adjudication 
by 2 
physicians 
US adults 
aged >45 
27,348 918 5.7 
Age, sex, race, age-race 
interaction, socioeconomic 
factors, diabetes, hypertension, 
BMI, alcohol, smoking 
Myint (2006)(9) 
EPIC - 
Norfolk 
Occupational 
PA; leisure 
activities 
Stroke incidence 
Routine 
update from 
registry 
UK adults 
aged 40-79 
20,040 361 8.6 
Age, sex, BMI, SBP, cholesterol, 
smoking, alcohol, diabetes 
Odegaard (2011)(13) 
Singapore 
Chinese 
Health Study 
Recreational; 
Active Travel 
CVD mortality Registries 
Chinese 
adults aged 
45-74 
44,056 1,971 13 
Factors simultaneously (BMI, 
Alcohol, Smoking, Diet, sleep), 
Age, sex, dialect, age enrolled, 
education, diabetes, FHx of 
Colorectcal Ca, energy intake 
Park (2012)(22) KEPEC 
Recreational; 
Household 
CVD mortality 
Death 
Certificates 
Korean 
women aged 
>65 
5,079 607 8 
Age, self-reported health, self-
reported limitation in activity, 
smoking status, drinking status, 
body mass index, religion and 
other types of physical activity 
 
 
Patel (2013)(29) CHS 
Recreational; 
Occupational; 
Household; 
Active Travel 
Heart Failure 
incidence 
 Adjudicated 
by CHS Events 
committee 
 
US adults 
aged >65 
 
5,503 
 
1,037 
13 
 
Age, sex, race, education, 
income, alcohol, smoking, BMI, 
Coronary artery disease, MI, 
Hypertension, T2DM, Stroke, 
 
Acute MI incidence 
 
5,061 
 
Stroke incidence 
 
5,290 
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1st Author (year) 
Cohort 
name 
Domains of PA 
measured 
Disease outcome 
Disease 
ascertainment 
Population 
Sample 
size 
Number 
of events 
Follow-
up 
(years) 
Adjustments 
 
 
CVD mortality 
 
 
877 
Petersen (2012)(14)  
Copenhagen 
City Heart 
Study 
Recreational; 
Active Travel 
 
CHD incidence 
National 
patient 
register 
Danish men 
aged 20-93 
4,487 
1431 
13 
Age, education, smoking habits, 
alcohol, BMI, diabetes, 
cholesterol, blood pressure 
lowering therapy 
 
MI incidence 
795 
 
CHD incidence 
Danish 
women aged 
20-93 
5,956 
1,393 
MI incidence 589 
Reis (2011)(15) NIH-AARP 
Occupational; 
Household 
Type II Diabetes Self-report 
US men aged 
50-71 
 
114,996 11,031 
10 
Age, Race, educational 
attainment, marital status, BMI, 
diet, Alcohol, smoking 
US women 
aged 50-71 
 
92,483 6,969 
Sesso (1999)(2) CAHS 
Walking; stair 
climbing; 
sports 
CVD incidence 
Self-report of 
doctor 
diagnosis 
US women, 
37-69 
1,564 181 31 
Age, BMI, SBP, smoking, family 
history of CHD, diabetes 
Sesso (2000)(4) 
Harvard 
college 
alumni 
Walking; stair 
climbing; 
sports; leisure 
activities 
CHD incidence 
Self-report of 
doctor 
diagnosis 
US adults 
aged 39-88 
12,516 2,135 16.0 
Age, BMI, smoking, alcohol, 
hypertension, diabetes, early 
parental death 
Sherman (1994)(1) 
 
Framingham 
 
Recreational; 
Active Travel; 
Household; 
Occupational 
CVD mortality 
 
Death 
certificates 
 
US adults 
>75 285 81 10.0 
Age, SBP, cholesterol,  smoking, 
weight,  glucose  intolerance,  
co-morbidities 
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1st Author (year) 
Cohort 
name 
Domains of PA 
measured 
Disease outcome 
Disease 
ascertainment 
Population 
Sample 
size 
Number 
of events 
Follow-
up 
(years) 
Adjustments 
Shi (2013)(36)  SMHS 
Recreational; 
Active Travel 
Type II Diabetes 
Follow-up 
surveys and 
checking if 
conforms to 
American 
guidelines 
Chinese 
adults aged 
40-64 
51,464 1,304 5.4 
Age, Energy intake, Smoking, 
Alcohol, education level, 
occupation, income level, 
hypertension, family history of 
diabetes, BMI, WHR 
Soedamah (2013)(30) 
Health 
Survey for 
England and 
Scottish 
Health 
Survey 
Recreational; 
Household; 
Active Travel 
CVD mortality 
Patient-based 
database of 
deaths 
UK adults 
aged >40 
17,410 638 9.7 
Age, Marital status, Social Class, 
Ethnicity, Education, Survey 
year, cigarette smoking status, 
longstanding illness, BMI, 
domestic activity and alcohol 
Vergnaud (2013)(31) EPIC 
Recreational; 
Occupational; 
Household; 
Active Travel 
CVD Mortality 
Board of 
health & 
death indexes 
Europeans 
Aged 25-70 
378,864 23,828 12.8 
Sex, Age, Centre, Educational 
level, smoking, menopause, 
body fatness, calorific foods, 
plant foods, animal foods, 
alcohol & breastfeeding 
Wang (2013)(32) SMHS 
Recreational; 
Occupational; 
Household; 
Active Travel 
CVD mortality 
National 
patient 
register 
Chinese men 
40-74 
61,477 1,181 5.48 
Age, Educational level, Income, 
Occupation, alcohol, pack-years 
of smoking, energy intake, red 
meat, fruit, daily PA other than 
exercise, BMI, Hx of CVD, 
Diabetes, Hypertension, Liver 
disease 
Williams (2013)(16) NWHS 
Recreational; 
Active Travel; 
Household; 
Occupational 
 
 
 
CVD mortality 
 National 
death index 
US walking 
magazine 
subscribers 
(ages 
unknown) 
 
42,022 
 
834 
9.6 
Age, race, sex, education, prior 
heart attack, aspirin use, intake 
of meat, fruit, alcohol, BMI and 
medication use 
 Ischaemic Heart 
disease incidence 
443 
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1st Author (year) 
Cohort 
name 
Domains of PA 
measured 
Disease outcome 
Disease 
ascertainment 
Population 
Sample 
size 
Number 
of events 
Follow-
up 
(years) 
Adjustments 
Young (2014)(33) 
California 
Men's 
Health Study 
Recreational; 
Active Travel; 
Household; 
Occupational 
Heart Failure 
Incidence 
National 
patient 
register 
US men aged 
45-69 
82,695 3,473 7.8 
Age, race/ethnicity, education, 
income, BMI, smoking, 
hypertension, diabetes, anti-
hypertensives, HDL, glucose, 
triglycerides, food intake, 
alcohol 
Zhang, Q (2013)(29) Kailuan 
Recreational; 
Occupational; 
Household; 
Active Travel 
Stroke incidence: 
total, ischaemic 
and haemorrhagic 
2 yearly 
physician 
interviews and 
checking 
hospital 
discharges 
Chinese 
adults aged 
19-98 
91698 1,486 4 
Smoking, BMI, Diet, 
Cholesterol, Blood pressure, 
Glucose, Age, Sex, Hospital, 
Education, Income 
Zhang, Y (2011)(37) MONICA 
Recreational; 
Occupational 
Stroke incidence: 
total, ischaemic 
and haemorrhagic 
Computer 
registry 
Finnish 
adults 
Finnish 
adults aged 
25-74 
36,686 1,478 13.7 
Age, Study year, sex, smoking, 
physical activity, vegetable 
consumption, fruit 
consumption, education, 
alcohol, FHx of Stroke, Hx of 
Diabetes, BMI, SBP, Cholesterol 
 
AF – Atrial Fibrillation; BMI – Body Mass Index; BP – Blood pressure; BRHS – British Regional Heart Study; CAH  - College Alumni Health Study; CHS – Cardiovascular Health Study; CHD – 
Coronary Heart Disease; CVD Cardiovascular disease; EPIC – European Prospective Investigation of Cancer; FHx – family history; HWSS – Health and Wellbeing Surveillance System; Hx – 
history; JAAC - Japan Collaborative Cohort Study; JPHC – Japan Public Health Center based prospective study; KEPEC – Korean Elderly Pharmacoepidemiologic Cohort; LTA - Leisure Time 
Physical Activity; LVH – Left Ventricular hypertrophy; MI – Myocardial Infarction; Monica – the WHO Multinational Monitoring of Trends and Determinants of Cardiovascular Disease; NHANES 
– National Health and Nutrition Examination Survey; NHS – National Health Service; NHS – Nurses’ Health Study; NIH-AARP – National Institute of Health – American Association of Retired 
Persons; NWHS - National Walker's Health Study; PA – physical activity; REGARDS – Reasons for Geographic Differences in Stroke; SBP – Systolic Blood Pressure; SMHS - Shanghai Men's 
Health Study; SOF – Study of Osteoporotic Fractures; SOF – Study of Osteoporotic Fractures; T2DM Type II Diabetes Mellitus; US – United States; VTE – Venous thromboembolism; WHI – 
Women’s Health Initiative; CHS – Cardiovascular Health Study; WHR - Waist-to-hip ratio
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Table S4. Excluded studies and data points evaluating the effect of physical activity on CVD outcome and Type II Diabetes Incidence.  
Note these studies have been excluded as only one data point for the disease outcome was found, therefore it was decided not to include in a meta-
analysis 
1st Author 
(year) 
Cohort 
name 
Domains of PA 
measured 
Disease outcome 
Disease 
ascertainme
nt 
Population 
Sample 
size 
Number 
of events 
Follow
-up 
(years) 
Adjustments 
Patel 
(2013)(29) 
CHS 
Recreational, 
Occupational, 
Household, 
Active Travel 
Angina incidence 
Adjudicated 
by CHS 
Events 
committee 
 
Age >65 
 
5,503 
 
4708 
13 
 
Age, sex, race, education, 
income, alcohol, smoking, BMI, 
Coronary artery disease, 
Myocardial infarction, 
Hypertension, T2DM and Stroke 
 
Williams 
(2013)(16) 
NWHS 
Recreational, 
Active Travel, 
Household, 
Occupational 
 
 
Cerebrovascular 
disease mortality 
 
National 
death index 
Walking 
magazine 
subscribers 
 
42,022 
147 
9.6 
Age, race, sex, education, prior 
heart attack, aspirin use, intake of 
meat, fruit, alcohol, BMI and 
medication use 
 
 
Heart Failure 
mortality 
 
53 
 
Diabetes mortality 
 
48 
Wattanakit 
(2012)(38) 
ARIC 
Recreational, 
occupational 
Venous 
thromboembolism 
incidence 
Telephoning 
patients & 
hospital 
discharge list 
Adults aged 
45-64 
15340 468 15.5 
BMI, age, race, field centre, and 
sex 
 
ARIC – Atherosclerosis Risk in Communities Study; BMI – Body Mass Index; CHS – Cardiovascular Health Study; NWHS - National Walker's Health Study.  
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Table S5. Sensitivity analyses: results restricted to studies that achieved at least six of the eight 
study criteria; studies with implausible PA values removed. Meta-analyses adjusted for body 
weight for 11.25 METhr/week increase in PA, with a 0.25 power transformation 
 High quality studies 
only 
Implausible PA ranges 
removed 
Main results (for 
comparison) 
Condition (ICD-10 
code) 
RR (95% CI)  I2 RR (95% CI)  I2 RR (95% CI)  I2 
CVD incidence (I00-
I99) 
n/a  0.83 (0.77, 
0.89) 
0.0% 0.83 (0.77, 
0.89) 
0.0% 
CVD mortality (I00-I99) 0.81 (0.76, 
0.86) 
25.1% 0.76 (0.69, 
0.84) 
78.2% 0.77 (0.71, 
0.84) 
73.6% 
Stroke incidence (I60-
I69) 
0.81 (0.75, 
0.87) 
0.0% 0.82 (0.77, 
0.87) 
0.0% 0.82 (0.77, 
0.87) 
0.0% 
CHD incidence (I20-
I25) 
0.76 (0.67, 
0.86) 
0.0% 0.79 (0.74, 
0.86) 
0.0% 0.80 (0.75, 
0.86) 
0.0% 
CHD mortality (I20-25) 0.80 (0.58, 
1.09) 
59.1% 0.80 (0.58, 
1.09) 
59.1% 0.80 (0.58, 
1.09) 
59.1% 
Heart failure incidence 
(I50) 
0.79 (0.73, 
0.85) 
0.0% 0.80 (0.75, 
0.86) 
4.0% 0.81 (0.76, 
0.86) 
0.0% 
Myocardial infarction 
incidence (I21-22) 
0.75 (0.62, 
0.89) 
0.0% 0.75 (0.62, 
0.89) 
0.0% 0.75 (0.62, 
0.89) 
0.0% 
Type 2 diabetes 
incidence (E11) 
0.71 (0.52, 
0.97) 
27.3% 0.74 (0.72, 
0.77) 
0.0% 0.74 (0.72, 
0.77) 
0.0% 
n/a - too few studies for a meta-analysis 
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Table S6. Meta-regressions: Association between study-level variables and CVD mortality relative 
risk for 11.25 METhours/week increase in physical activity, assuming .025 power transformation 
Study-level variables Meta-regression 
coefficient 
p 
Quality score (minimum = 1; maximum = 8) 0.07 0.023 
Method of obesity measurement (0 = subjective; 1 = 
objective) 
0.24 0.001 
Validated PA measurement (0 = no; 1 = yes) 0.07 0.342 
Gender (0 = men only; 1 = women only) -0.03 0.654 
Mean age of participants (0 = under 65; 1 = 65+) -0.09 0.287 
Active travel (0 = not included; 1 = included) -0.07 0.480 
Occupational PA (0 = not included; 1 = included) 0.06 0.351 
Household PA (0 = not included; 1 = included) -0.07 0.330 
Mean follow-up years 0.01 0.381 
Geography (baseline – US): Europe 0.07 0.000 
Geography (baseline – US): Other 0.15 0.000 
 
NB: CVD mortality selected as outcome as it has the most data lines (17 data lines from 14 studies) 
and considerable heterogeneity. Meta-regression weighted by the inverse of the standard error. 
Results are not mutually adjusted. 
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Supplemental Figures 
Figures S1-7: Meta-analysis of 11.25 METhr/week increase in physical activity for cardiovascular 
disease and diabetes health outcomes 
Meta-analysis results are displayed for all the power 0.25 analyses, adjusted for body weight. 
Conditions are given in the figures.  
S1: CVD incidence 
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S2: Stroke incidence 
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S3: CHD incidence
 
 
S4: CHD mortality
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S5: Heart failure incidence 
 
 
S6:  MI incidence
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S7: Diabetes incidence
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Figures S8-S10: Dose-response relationship for the effect of 11.25 METhr/week increase in physical 
activity for the cardiovascular disease and diabetes health outcomes  
Meta-analysis results are displayed for all the power 0.25 analyses, adjusted for body weight. 
Conditions are given in the figures.  
Figure S8: CVD mortality 
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Figure S9: CVD incidence  
 
 
Figure S10: T2DM incidence 
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Figure S11. Chart showing additional MET hours per week in highest exposure category for CVD 
mortality studies  
 
 
The green line indicates the recommended PA level of 11.25METhr/week 
The red lines indicate the threshold for implausibly high levels (10 times the recommendation) or 
implausibly low (less than 30 minutes as demonstrated by the lower line) 
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Figure S12. Chart showing additional METs of less than 30 in highest exposure category CVD 
mortality studies  
 
 
Please note the green line relates to recommended PA of 11.25METs, compared with the red line 
this time pertaining to the lower limit of <30 mins per week.  
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Figure S13. Chart showing additional METs of less than 30 in highest exposure category for T2DM 
incidence studies  
 
 
Please note the green line relates to recommended PA of 11.25METs, compared with the red line 
this time pertaining to the lower limit of <30 mins per week.  
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Figures S14—S20: Funnel plots for meta-analyses of 11.25 METhr/week increase in physical 
activity for cardiovascular disease and diabetes health outcomes 
Meta-analysis results are displayed for all the power 0.25 analyses, adjusted for body weight. 
Conditions are given in the figures.  
 
S14: CVD incidence 
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S15: Stroke incidence
 
 
S16: CHD incidence 
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S17: CHD mortality
 
 
S18: Heart failure incidence
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S19: MI incidence
 
 
S20: Diabetes incidence
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